SAN
FRANCISCO, Aug. 30, 2022 /PRNewswire/ -- Invitae
(NYSE: NVTA), a leading medical genetics company, today announced
that members of its management team will participate in the
following investor conference:
- Morgan Stanley 20th Annual Global Healthcare
Conference – Fireside chat on Tuesday, September 13, 2022, at 8:00 a.m. Eastern Time in New York City, New
York.
A live audio webcast of the fireside chat may be accessed by
visiting the investors section of the company website at
ir.invitae.com. A replay of the webcast will be available shortly
after the conclusion of the presentation.
About Invitae
Invitae Corporation (NYSE: NVTA) is
a leading medical genetics company whose mission is to bring
comprehensive genetic information into mainstream medicine to
improve healthcare for billions of people. Invitae's goal is to
aggregate the world's genetic tests into a single service with
higher quality, faster turnaround time, and lower prices. For more
information, visit the company's website at invitae.com.
Contact for Invitae:
Hoki
Luk
ir@invitae.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/invitae-to-present-at-upcoming-investor-conference-301614963.html
SOURCE Invitae Corporation